Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Pallesen

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Nature Communications|February 5, 2022
Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimerZiyang Xu, Susanne Walker, Megan C Wise, et al.
Nature Immunology|February 3, 2026
Rapid elicitation of neutralizing Asn332-glycan-independent antibodies to the V3-glycan epitope of HIV-1 Env in nonhuman primatesIgnacio Relano-Rodriguez, Jianqiu Du, Zi Jie Lin, et al.
Nature Microbiology|November 15, 2016
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerabilityMarit J van Gils, Tom L G M van den Kerkhof, Gabriel Ozorowski, et al.
Cell Reports|January 29, 2022
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protectionKylie M Konrath, Kevin Liaw, Yuanhan Wu, et al.
Science (New York, N.Y.)|November 3, 2018
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutininNick S Laursen, Robert H E Friesen, Xueyong Zhu, et al.
Nature Communications|October 6, 2022
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2Elizabeth M Parzych, Jianqiu Du, Ali R Ali, et al.
Cell Reports|May 11, 2016
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteKatie A Howell, Xiangguo Qiu, Jennifer M Brannan, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Deep Mining of the Human Antibody Repertoire Identifies Frequent and Genetically Diverse CDRH3 Topologies Targetable by VaccinationRumi Habib, Shahlo O Solieva, Zi Jie Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2026
Deep mining of the human antibody repertoire identifies frequent and genetically diverse CDRH3 topologies targetable by vaccinationRumi Habib, Shahlo O Solieva, Zi Jie Lin, et al.
Cell|August 11, 2018
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to ProtectionErica Ollmann Saphire, Sharon L Schendel, Marnie L Fusco, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Nature Communications|February 5, 2022
Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimerZiyang Xu, Susanne Walker, Megan C Wise, et al.
Nature Immunology|February 3, 2026
Rapid elicitation of neutralizing Asn332-glycan-independent antibodies to the V3-glycan epitope of HIV-1 Env in nonhuman primatesIgnacio Relano-Rodriguez, Jianqiu Du, Zi Jie Lin, et al.
Nature Microbiology|November 15, 2016
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerabilityMarit J van Gils, Tom L G M van den Kerkhof, Gabriel Ozorowski, et al.
Cell Reports|January 29, 2022
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protectionKylie M Konrath, Kevin Liaw, Yuanhan Wu, et al.
Science (New York, N.Y.)|November 3, 2018
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutininNick S Laursen, Robert H E Friesen, Xueyong Zhu, et al.
Nature Communications|October 6, 2022
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2Elizabeth M Parzych, Jianqiu Du, Ali R Ali, et al.
Cell Reports|May 11, 2016
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteKatie A Howell, Xiangguo Qiu, Jennifer M Brannan, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Deep Mining of the Human Antibody Repertoire Identifies Frequent and Genetically Diverse CDRH3 Topologies Targetable by VaccinationRumi Habib, Shahlo O Solieva, Zi Jie Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2026
Deep mining of the human antibody repertoire identifies frequent and genetically diverse CDRH3 topologies targetable by vaccinationRumi Habib, Shahlo O Solieva, Zi Jie Lin, et al.
Cell|August 11, 2018
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to ProtectionErica Ollmann Saphire, Sharon L Schendel, Marnie L Fusco, et al.
Pageof 4